期刊文献+

阿尔茨海默病转线粒体DNA细胞模型胞质钙稳态的改变 被引量:3

Alteration of Cytosolic Calcium in mtDNA-transferred Cells of Alzheimer's Disease
下载PDF
导出
摘要 目的观察阿尔茨海默病(Alzheimer's disease,AD)转线粒体DNA细胞模型胞质游离钙水平,探讨线粒体DNA(mitochondrial DNA,mtDNA)缺陷在AD发病中的作用。方法 将正常青年人、正常老年人和AD患者的血小板分别与无mtDNA细胞融合,建立转mtDNA细胞模型。采用微测量法测定细胞色素C氧化酶(cytochrome C oxidase,COX)的活性;用荧光探针Fluo-3标记胞质内游离钙离子,激光共聚焦显微镜和流式细胞仪观察细胞胞质钙离子荧光强度。结果 AD转mtDNA细胞COX活性与正常老年对照相比差异有统计学意义(P<0.05);静息状态胞质钙离子浓度升高,氧化磷酸化解耦联剂CCCP刺激后胞质钙离子的调节能力明显降低。结论 AD患者线粒体存在COX缺陷,使线粒体钙库功能下降,导致细胞内胞质钙稳态失衡。 Objective:To investigate the level of cytosolic free calcium in mitochondria DNA-transferred cells of Alzheimer's disease and the influence of mitochondrial DNA(mtDNA) deficiency on calcium regulation capacity of cells.Methods:Platelets from AD patients and aged control persons were fused with mtDNA-depleted cells to develop mtDNA-transferred cell model.Cytochrome C oxidase(COX) activity was determined by microplate assay;cytosolic calcium was labeled with Fluo-3 and fluorescence density was detected with laser scan confocal microscope(LSCM) and flow cytometer(FCM).Results:COX activity was reduced in AD mtDNA-transferred cells when compared with aged control and young control.The resting cytosolic calcium was elevated in AD mtDNA-transferred cells compared with the controls and decreased when stimulated by carbonyl cyanide m-chlorophenyl hydrazone(CCCP).Conclusion:The transfer of AD mtDNA was sufficient to produce pathological changes in cytosolic calcium regulation.
出处 《首都医科大学学报》 CAS 北大核心 2011年第1期67-72,共6页 Journal of Capital Medical University
基金 国家自然科学基金项目(30701092 30973513) 北京市自然科学基金项目(7072033) 北京市新世纪百千万人才工程(2008) 北京市卫生局高层次卫生技术人才(215工程)~~
关键词 阿尔茨海默病 线粒体 转线粒体DNA细胞 细胞色素C氧化酶 胞质钙 Alzheimer's disease mitochondria mtDNA-transferred cells cytochrom C cytosolic calcium
  • 相关文献

参考文献3

二级参考文献56

  • 1[1]Davis, R.E., S. Miller, C. Hermstadt, S.S. Ghosh, E. Fahy, L.A. Shinobu, D. Galasko, L.J. Thal, M.F. Beal, N. Howell and W.D. Parker, 1997, Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA, 94: 4526-4531.
  • 2[2]Swerdlow, R. H., J.K. Parks, D.S. Cassarino, P.A. Trimmer, S.W. Miller, D.J. Maguire, J.P. Sheehan, R.S. Maguire, R.E. Davis and W. D. Parker, 1998, Mitochondria in sporadic amyotrophic lateral sclerosis. Expel. Neurol., 153:135 - 142.
  • 3[3]Schapira, A. H. V., M. Gu, J.W. Taanman, S.J. Tabrizi, T. Seaton, M. Cleeter and J. M. Cooper, 1998, Mitochondia in the etiology and pathogenesis of Parkinson's disease. Ann. Neurol., 44(suppl 1): S89 - S98.
  • 4[4]Markesbery, W.R. and J.M. Carney, 1999, Oxidative alterations in Alzheimer' s disease. Brain Pathol., 9:133 - 146.
  • 5[5]Hsieh, R.H., J.Y. Li, C.Y. Pang and Y.H. Wei, 2001, A novel mutation in the mitochondrial 16S rRNA gene in a patient with MELAS syndrome, diabetes mellitus, hyperthyroidism and cardiomyopathy. J. Biomed.Sci., 8(4) :328 - 35.
  • 6[6]Albers, D.S. and M.F. Beal, 2002, Mitcchondrial dysfunction in progressive supranuclear palsy. Neurochem.Int. , 40(6) :559 - 64.
  • 7[7]Brown, M. D. , J.C. Allen, G.P. Van Stavem, N.j. Newman and D.C. Wallace, 2001, Clinical, genetic, and biochemical characterization of a Leber hereditary op tic neuropathy family containing both the 11778 and 14484 primary mutations. Am. J. Med. Genet., 104(4):331-8.
  • 8[8]Swerdlow, R. H. , J.K. Parks, D.S. Cassarino, D.J. Maguire, R.S. Maguire, J.P. Bennett, R.E. Davis and W.D. Parker, 1997, Cybrids in Alzheimer's disease: Acellular model of the disease? Neurology, 49:918-925.
  • 9[9]Miller, S.W., P.A. Trimmer, W.D. Parker, Jr. , and R.E. Davis, 1996, Creation and characterization of mito chondrial DNA - depleted cell lines with "neuronal-like" properties. J. Neurochem. , 67:1897 - 1907.
  • 10[10]Tabrizi, S.J., J.M. Cooper and A. H. V. Schapira, 1998, Mitochodrial DNA in focal dystonia: A cybrid anal ysis. Ann. Neurol., 44:258-261.

共引文献15

同被引文献131

引证文献3

二级引证文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部